Tokyo, Japan

Yoshihiko Isobe


Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 1996-1998

Loading Chart...
2 patents (USPTO):

Title: Innovations of Yoshihiko Isobe

Introduction

Yoshihiko Isobe is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target gastrointestinal conditions. With a total of 2 patents, his work has garnered attention for its potential therapeutic applications.

Latest Patents

One of Yoshihiko Isobe's latest patents involves a heterocyclic compound known as Endo-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl) 1-isopropyl-2(1H)-quinolone-3-carboxylate. This compound acts on the serotonin 4 receptor, exhibiting serotonin-like receptor stimulating activity. As a result, it plays a crucial role in activating gastrointestinal motor functions, making it effective for improving various gastrointestinal conditions such as heartburn, anorexia, bowel pain, and abdominal distension. Additionally, it has potential applications in treating gastro-esophageal reflux, intestinal pseudo-obstruction, and constipation.

Career Highlights

Yoshihiko Isobe is associated with Taisho Pharmaceutical Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong focus on addressing gastrointestinal disorders, which affect a significant portion of the population.

Collaborations

Throughout his career, Yoshihiko has collaborated with esteemed colleagues, including Yutaka Ohuchi and Masaji Suzuki. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Yoshihiko Isobe's contributions to the field of pharmaceuticals, particularly in gastrointestinal health, highlight his innovative spirit and dedication to improving patient outcomes. His patents reflect a commitment to addressing pressing medical needs through scientific research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…